絞り込み

16644

広告

Influence of the reclassification of NIFTP as a uncertain tumor on risk of malignancy for the diagnostic categories according to the Bethesda System for Reporting Thyroid Cytopathology.

著者 Kopczyński J , Suligowska A , Niemyska K , Palyga I , Walczyk A , Gąsior-Perczak D , Kowalik A , Hińcza K , Mężyk R , Góźdź S , Kowalska A
Endokrynol Pol.2019 Mar 07 ; ():.
この記事をPubMed上で見るPubMedで表示
この記事をGoogle翻訳上で見る Google翻訳で開く

スターを付ける スターを付ける     (1view , 0users)

Full Text Sources

Medical

Miscellaneous

The noninvasive encapsulated, follicular variant of papillary thyroid carcinoma was reclassified as Noninvasive Follicular Thyroid Neoplasm with Papillary-like Nuclear Features (NIFTP). The exclusion of NIFTP from the group of malignant tumors decreases the risk of malignancy (RoM) as defined by the Bethesda System for Reporting Thyroid Cytopathology (TBSRTC). The aim of the present study was to evaluate the RoM for each category in TBSRTC with and without exclusion of NIFTP from the tally of malignancies.
PMID: 30845342 [PubMed - as supplied by publisher]
印刷用ページを開く Endnote用テキストダウンロード